Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Alpha Diallo et al.|The Lancet Infectious Diseases|2021Cited by 344
High-flow nasal oxygen therapy alone or with non-invasive ventilation in immunocompromised patients admitted to ICU for acute hypoxemic respiratory failure: the randomised multicentre controlled FLORALI-IM protocolRémi Coudroy, Arnaud W. Thille, Jean‐Pierre Frat et al.|BMJ Open|2019Cited by 33
Factors associated with ICU mortality and long-term outcomes in immunocompromised patients admitted to the intensive care unit for acute respiratory failureMaguy Metais, Achille Kouatchet, Jean‐Pierre Frat et al.|Annals of Intensive Care|2025Cited by 7